Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
NHC Key Laboratory of Prevention and treatment of Cerebrovascular Disease, Zhengzhou, Henan, China.
Ann Clin Transl Neurol. 2023 Jul;10(7):1119-1135. doi: 10.1002/acn3.51794. Epub 2023 May 26.
Leukoencephalopathies are a group of heterogeneous disorders characterized by the degeneration of white matter, resulting in a variety of progressive neurological symptoms. To date, over 60 genes linked to genetic leukoencephalopathies have been discovered through whole-exome sequencing (WES) and long-read sequencing. Nonetheless, the genetic diversity and clinical variability of these disorders among various racial groups remain largely unknown. Therefore, this study aims to analyze the genetic spectrum and clinical features of Chinese adult leukoencephalopathies and compare the genetic profiles in different populations.
A total of 129 patients suspected of possible genetic leukoencephalopathy were enrolled and underwent WES and dynamic mutation analysis. Bioinformatics tools were used to predict the pathogenicity of these mutations. Skin biopsies were conducted for further diagnosis. Genetic data sources from different populations were collected from published articles.
Genetic diagnosis was established in 48.1% of patients, with WES identifying 57 pathogenic or likely pathogenic variants in 39.5% of cases. NOTCH3 and NOTCH2NLC were the most common mutated genes, accounting for 12.4% and 8.5% of cases, respectively. Dynamic mutation analysis revealed NOTCH2NLC GGC repeat expansions in 8.5% of patients. Different mutations resulted in varying clinical symptoms and imaging findings. Comparisons of genetic profiles between different populations showed distinct mutational spectrums in adult leukoencephalopathies.
This study highlights the importance of genetic testing for accurate diagnosis and improved clinical management of these disorders. It also sheds light on the genetic heterogeneity of adult leukoencephalopathies across different races, emphasizing the need for further research on this topic.
脑白质病是一组异质性疾病,其特征为白质退化,导致各种进行性神经症状。迄今为止,通过全外显子组测序(WES)和长读测序已发现 60 多个与遗传性脑白质病相关的基因。然而,不同种族人群中这些疾病的遗传多样性和临床变异性在很大程度上仍不清楚。因此,本研究旨在分析中国成人脑白质病的遗传谱和临床特征,并比较不同人群的遗传谱。
共纳入 129 例疑似遗传性脑白质病的患者,进行 WES 和动态突变分析。使用生物信息学工具预测这些突变的致病性。对皮肤活检进行进一步诊断。从已发表的文章中收集不同人群的遗传数据来源。
48.1%的患者确定了遗传诊断,WES 在 39.5%的病例中发现了 57 个致病性或可能致病性变异。NOTCH3 和 NOTCH2NLC 是最常见的突变基因,分别占 12.4%和 8.5%。动态突变分析显示 8.5%的患者存在 NOTCH2NLC GGC 重复扩增。不同的突变导致不同的临床症状和影像学发现。不同人群的遗传谱比较显示成人脑白质病的突变谱存在明显差异。
本研究强调了遗传检测对这些疾病的准确诊断和临床管理的重要性。它还揭示了不同种族成人脑白质病的遗传异质性,强调了进一步研究这一课题的必要性。